1. Home
  2. CALC vs NTIP Comparison

CALC vs NTIP Comparison

Compare CALC & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • NTIP
  • Stock Information
  • Founded
  • CALC 2011
  • NTIP 1990
  • Country
  • CALC United States
  • NTIP United States
  • Employees
  • CALC N/A
  • NTIP N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • NTIP Multi-Sector Companies
  • Sector
  • CALC Health Care
  • NTIP Miscellaneous
  • Exchange
  • CALC Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • CALC 36.0M
  • NTIP 32.9M
  • IPO Year
  • CALC N/A
  • NTIP 1998
  • Fundamental
  • Price
  • CALC $2.35
  • NTIP $1.38
  • Analyst Decision
  • CALC Strong Buy
  • NTIP
  • Analyst Count
  • CALC 5
  • NTIP 0
  • Target Price
  • CALC $18.20
  • NTIP N/A
  • AVG Volume (30 Days)
  • CALC 31.5K
  • NTIP 15.2K
  • Earning Date
  • CALC 03-27-2025
  • NTIP 03-07-2025
  • Dividend Yield
  • CALC N/A
  • NTIP 7.09%
  • EPS Growth
  • CALC N/A
  • NTIP N/A
  • EPS
  • CALC N/A
  • NTIP N/A
  • Revenue
  • CALC N/A
  • NTIP $1,881,000.00
  • Revenue This Year
  • CALC N/A
  • NTIP N/A
  • Revenue Next Year
  • CALC N/A
  • NTIP N/A
  • P/E Ratio
  • CALC N/A
  • NTIP N/A
  • Revenue Growth
  • CALC N/A
  • NTIP 129.39
  • 52 Week Low
  • CALC $2.05
  • NTIP $1.22
  • 52 Week High
  • CALC $6.27
  • NTIP $2.25
  • Technical
  • Relative Strength Index (RSI)
  • CALC 35.06
  • NTIP 50.88
  • Support Level
  • CALC $2.36
  • NTIP $1.34
  • Resistance Level
  • CALC $2.66
  • NTIP $1.42
  • Average True Range (ATR)
  • CALC 0.24
  • NTIP 0.03
  • MACD
  • CALC -0.02
  • NTIP 0.00
  • Stochastic Oscillator
  • CALC 4.13
  • NTIP 50.00

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: